Randomised, parallel-group trial to compare the efficacy and safety of GLP-1 analogue: liraglutide and DPP-4 inhibitor: sitagliptin as combination therapy in subjects with type 2 diabetes using sulfonylurea.
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 23 Oct 2014
At a glance
- Drugs Liraglutide (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 09 Feb 2011 New trial record